![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Grants EUA for Quest Diagnostics’ At-Home COVID-19 Test
FDA Grants EUA for Quest Diagnostics’ At-Home COVID-19 Test
![Quest Diagnostics logo](https://www.fdanews.com/ext/resources/test/Device_Images6/Quest-Diagnostic-logo.gif?t=1583786657&width=430)
Quest Diagnostics has received an Emergency Use Authorization (EUA) from the FDA for its coronavirus self-collection test kit.
The kit includes a nasal swab to gather a specimen at home or in a healthcare setting. The specimen is then shipped overnight at room temperature for testing. Results are delivered through a patient portal and a mobile app.
Specimens collected using the kit are analyzed on the company’s SARS-CoV-2 RT-PCR test, which received an EUA in March.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct